All News

Kevin DeMass, RPh, is the owner and leader of a talented team of professionals that encounters a wide variety of patients, ailments, and medications.

Vaccination is first line of defense.

A new systematic review demonstrates efficacy of direct-acting antiviral therapies and supports a recommendation for universal screening of hepatitis C virus.

The FDA announced the first drug shortage due to COVID-19, and pharmacies are having challenges keeping face masks and hand sanitizers stocked.

Pyrimethamine (Daraprim) tablets are used to treat toxoplasmosis.

British study supports exogenous boosting theory.

Rimegepant (Nurtec ODT, Biohaven),a fast-acting orally disintegrating tablet, delivers quick and sustained efficacy for patients with migraine.

In new comments to the US government, several pharmacy groups say that mergers of major companies have had significant anticompetitive effects without improving the cost and quality of health care.

A new study tested the investigational drug in combination with proton pump inhibitors for patients with gastroesophageal reflux disease.

The differences between antihypertension medication classes were generally small and nuanced in terms of their effect on reducing cardiovascular risks.

Separately, a pharmacy association executive urges Americans to receive the flu vaccine.

Regardless of naloxone availability, rural pharmacies can serve as an educational resource for individuals seeking access to the medication.

A secondary analysis presented at the American Stroke Association’s International Stroke Conference 2020 confirmed the safety of apixaban treatment.

Bempedoic acid (Nexletol, Esperion) is a new lipid-lowering therapy option for patients with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease.

Several pharmacy groups said they will file a brief in the Supreme Court case, Rutledge v. the Pharmaceutical Care Management Association.

Patient access to portal self-management tools through mobile devices may help significantly improve diabetes care.

Eptinezumab-jjmr (Vyepti, Lundbeck) decreased mean monthly migraine days in adult patients in 2 phase 3 clinical trials.

FDA responds to shortages, plus other important updates.

Patients receiving methadone treatment are at most risk of overdosing during the first 4 weeks of treatment initiation and following the end of treatment.

Express Scripts’ annual Drug Trend Report highlights top contributors to prescription drug spending in 2019.

The FreeStyle Libre system decreased HbA1c, increased time in glucose range, and reduced diabetes complications.

Despite sickle cell disease's (SCD) lower profile, 3 new SCD drugs were approved in the last 3 years, with 2 approvals occurring in late 2019

Quicker referral time to youth-friendly care services could help younger patients with HIV achieve better outcomes.

Greg Jones, RPh, MBA, director of pharmacy services and his team are doing some amazing things in pharmacy.

NACDS praised the new Kaiser Permanente model, which utilizes pharmacists and pharmacy technicians to save significant health care costs. 

The pharmacist’s role in diabetes management is more important than ever before, given the number of patients with diabetes and the number of options available for treating them.

Novo Nordisk has fired the first “shot heard around the health care world.”